708 related articles for article (PubMed ID: 20095264)
1. Development of prototype shielded cervical intracavitary brachytherapy applicators compatible with CT and MR imaging.
Price MJ; Jackson EF; Gifford KA; Eifel PJ; Mourtada F
Med Phys; 2009 Dec; 36(12):5515-24. PubMed ID: 20095264
[TBL] [Abstract][Full Text] [Related]
2. Monte Carlo model for a prototype CT-compatible, anatomically adaptive, shielded intracavitary brachytherapy applicator for the treatment of cervical cancer.
Price MJ; Gifford KA; Horton JL; Eifel PJ; Gillin MT; Lawyer AA; Mourtada F
Med Phys; 2009 Sep; 36(9):4147-55. PubMed ID: 19810488
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional applicator system for carcinoma of the uterine cervix.
Weeks KJ; Montana GS
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):455-63. PubMed ID: 9069321
[TBL] [Abstract][Full Text] [Related]
4. An analysis of the effect of ovoid shields in a selectron-LDR cervical applicator on dose distributions in rectum and bladder.
Steggerda MJ; Moonen LM; Damen EM; Lebesque JV
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):237-45. PubMed ID: 9300759
[TBL] [Abstract][Full Text] [Related]
5. HDR brachytherapy of rectal cancer using a novel grooved-shielding applicator design.
Webster MJ; Devic S; Vuong T; Han DY; Scanderbeg D; Choi D; Song B; Song WY
Med Phys; 2013 Sep; 40(9):091704. PubMed ID: 24007137
[TBL] [Abstract][Full Text] [Related]
6. Accurate localization of intracavitary brachytherapy applicators from 3D CT imaging studies.
Lerma FA; Williamson JF
Med Phys; 2002 Mar; 29(3):325-33. PubMed ID: 11929015
[TBL] [Abstract][Full Text] [Related]
7. A monte carlo dosimetry study of vaginal 192Ir brachytherapy applications with a shielded cylindrical applicator set.
Lymperopoulou G; Pantelis E; Papagiannis P; Rozaki-Mavrouli H; Sakelliou L; Baltas D; Karaiskos P
Med Phys; 2004 Nov; 31(11):3080-6. PubMed ID: 15587661
[TBL] [Abstract][Full Text] [Related]
8. A CT-compatible version of the Fletcher system intracavitary applicator: clinical application and 3-dimensional treatment planning.
Schoeppel SL; Fraass BA; Hopkins MP; La Vigne ML; Lichter AS; McShan DL; Noffsinger S; Perez-Tamayo C; Roberts JA
Int J Radiat Oncol Biol Phys; 1989 Nov; 17(5):1103-9. PubMed ID: 2808045
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric accuracy of a deterministic radiation transport based 192Ir brachytherapy treatment planning system. Part II: Monte Carlo and experimental verification of a multiple source dwell position plan employing a shielded applicator.
Petrokokkinos L; Zourari K; Pantelis E; Moutsatsos A; Karaiskos P; Sakelliou L; Seimenis I; Georgiou E; Papagiannis P
Med Phys; 2011 Apr; 38(4):1981-92. PubMed ID: 21626931
[TBL] [Abstract][Full Text] [Related]
10. SU-E-T-318: Source Position Localization for ICBT Tandem & Ovoid Applicators Utilizing Oncentra Brachy Applicator Modeling.
Kemp J; Price M
Med Phys; 2012 Jun; 39(6Part14):3777. PubMed ID: 28517249
[TBL] [Abstract][Full Text] [Related]
11. Applicator reconstruction in MRI 3D image-based dose planning of brachytherapy for cervical cancer.
Haack S; Nielsen SK; Lindegaard JC; Gelineck J; Tanderup K
Radiother Oncol; 2009 May; 91(2):187-93. PubMed ID: 18977049
[TBL] [Abstract][Full Text] [Related]
12. Pilot study of a computed tomography-compatible shielded intracavitary brachytherapy applicator for treatment of cervical cancer.
Klopp AH; Mourtada F; Yu ZH; Beadle BM; Munsell MF; Jhingran A; Eifel PJ
Pract Radiat Oncol; 2013; 3(2):115-23. PubMed ID: 24674314
[TBL] [Abstract][Full Text] [Related]
13. Screens in ovoids of a Selectron cervix applicator.
Meertens H; van der Laarse R
Radiother Oncol; 1985 Jan; 3(1):69-80. PubMed ID: 3975442
[TBL] [Abstract][Full Text] [Related]
14. A three-dimensional computed tomography-assisted Monte Carlo evaluation of ovoid shielding on the dose to the bladder and rectum in intracavitary radiotherapy for cervical cancer.
Gifford KA; Horton JL; Pelloski CE; Jhingran A; Court LE; Mourtada F; Eifel PJ
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):615-21. PubMed ID: 16168853
[TBL] [Abstract][Full Text] [Related]
15. Quantitative CT assessment of a novel direction-modulated brachytherapy tandem applicator.
Elzibak AH; Kager PM; Soliman A; Paudel MR; Safigholi H; Han DY; Karotki A; Ravi A; Song WY
Brachytherapy; 2018; 17(2):465-475. PubMed ID: 29174936
[TBL] [Abstract][Full Text] [Related]
16. Commissioning of a grid-based Boltzmann solver for cervical cancer brachytherapy treatment planning with shielded colpostats.
Mikell JK; Klopp AH; Price M; Mourtada F
Brachytherapy; 2013; 12(6):645-53. PubMed ID: 23891341
[TBL] [Abstract][Full Text] [Related]
17. Direction modulated brachytherapy (DMBT) tandem applicator for cervical cancer treatment: Choosing the optimal shielding material.
Safigholi H; Han DY; Soliman A; Song WY
Med Phys; 2018 Jun; ():. PubMed ID: 29858499
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Monte Carlo calculations around a Fletcher Suit Delclos ovoid with radiochromic film and normoxic polymer gel dosimetry.
Gifford KA; Horton JL; Jackson EF; Steger TR; Heard MP; Mourtada F; Lawyer AA; Ibbott GS
Med Phys; 2005 Jul; 32(7):2288-94. PubMed ID: 16121584
[TBL] [Abstract][Full Text] [Related]
19. Commissioning a CT-compatible LDR tandem and ovoid applicator using Monte Carlo calculation and 3D dosimetry.
Adamson J; Newton J; Yang Y; Steffey B; Cai J; Adamovics J; Oldham M; Chino J; Craciunescu O
Med Phys; 2012 Jul; 39(7):4515-23. PubMed ID: 22830783
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric characterization of a novel intracavitary mold applicator for 192Ir high dose rate endorectal brachytherapy treatment.
Poon E; Reniers B; Devic S; Vuong T; Verhaegen F
Med Phys; 2006 Dec; 33(12):4515-26. PubMed ID: 17278803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
